• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Vitamin K2 Market

    ID: MRFR/HC/6026-CR
    117 Pages
    Rahul Gotadki
    November 2021

    Vitamin K2 market Research Report Information By Product Type (MK-7 and MK-4 & Combination Drugs), By Source (Natural and Synthetic), By Form (Capsules & Tablets, Powder, and Oil), By Application (Nutraceutical and Food & Pharmaceutical), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vitamin K2 Market Infographic
    Purchase Options

    Vitamin K2 Market Summary

    As per MRFR analysis, the Vitamin K2 Market Size was estimated at 122.29 USD Billion in 2024. The Vitamin K2 industry is projected to grow from 127.82 USD Billion in 2025 to 198.88 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.52 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Vitamin K2 market is experiencing robust growth driven by health trends and innovative formulations.

    • Rising health consciousness among consumers is propelling the demand for Vitamin K2 supplements, particularly in North America.
    • Innovative product formulations are increasingly integrating Vitamin K2 into functional foods, enhancing its market appeal.
    • The MK-7 segment remains the largest, while MK-4 and combination drugs are emerging as the fastest-growing segments in the market.
    • Increased awareness of bone health and the growing demand for natural supplements are key drivers fueling market expansion.

    Market Size & Forecast

    2024 Market Size 122.29 (USD Billion)
    2035 Market Size 198.88 (USD Billion)
    CAGR (2025 - 2035) 4.52%

    Major Players

    NattoPharma (NO), Ginkgo BioWorks (US), Kappa Bioscience (NO), DSM Nutritional Products (CH), Nutraceutical Corporation (US), Jarrow Formulas (US), Life Extension (US), Swanson Health Products (US), NOW Foods (US)

    Vitamin K2 Market Trends

    The Vitamin K2 Market is currently experiencing a notable transformation, driven by increasing awareness regarding health benefits associated with this nutrient. As consumers become more health-conscious, the demand for Vitamin K2 supplements is on the rise. This nutrient is recognized for its role in bone health and cardiovascular wellness, which appears to resonate with a broad audience. Furthermore, the growing trend of preventive healthcare is likely to bolster the market, as individuals seek to enhance their overall well-being through dietary supplements. The expansion of e-commerce platforms also facilitates easier access to Vitamin K2 products, potentially increasing consumer engagement and market penetration. In addition, the Vitamin K2 Market is witnessing innovation in product formulations, with manufacturers exploring diverse delivery methods such as gummies, powders, and capsules. This diversification may cater to varying consumer preferences, thereby enhancing market appeal. Moreover, the integration of Vitamin K2 into functional foods and beverages suggests a shift towards incorporating this nutrient into everyday diets. As the market evolves, it seems poised for sustained growth, driven by both consumer demand and ongoing research into the health benefits of Vitamin K2.

    Rising Health Consciousness

    The increasing focus on health and wellness among consumers is driving the demand for Vitamin K2. Individuals are more inclined to seek supplements that support bone and cardiovascular health, leading to a surge in Vitamin K2 product offerings.

    Innovative Product Formulations

    Manufacturers are exploring various delivery formats for Vitamin K2, including gummies, powders, and capsules. This innovation caters to diverse consumer preferences, potentially enhancing market attractiveness.

    Integration into Functional Foods

    Vitamin K2 is increasingly being incorporated into functional foods and beverages. This trend reflects a growing consumer interest in enhancing daily diets with beneficial nutrients, thereby expanding the market's reach.

    The increasing recognition of Vitamin K2's role in bone health and cardiovascular wellness appears to be driving a notable surge in consumer demand and product innovation within the dietary supplement sector.

    U.S. Department of Agriculture

    Vitamin K2 Market Drivers

    Increased Awareness of Bone Health

    The rising awareness regarding bone health is a pivotal driver for the Vitamin K2 Market. As individuals become more informed about the importance of maintaining bone density and preventing osteoporosis, the demand for Vitamin K2 supplements is likely to surge. Research indicates that Vitamin K2 plays a crucial role in calcium metabolism, which is essential for bone health. In recent years, the market for bone health supplements has expanded significantly, with Vitamin K2 emerging as a key ingredient. This trend is further supported by the increasing prevalence of bone-related disorders, which has prompted consumers to seek preventive measures. Consequently, the Vitamin K2 Market is poised for growth as more individuals prioritize their bone health and seek effective nutritional solutions.

    Growing Demand for Natural Supplements

    The Vitamin K2 Market is experiencing a notable increase in demand for natural supplements. As consumers become more health-conscious, there is a discernible shift towards products that are perceived as natural and organic. This trend is driven by a growing skepticism towards synthetic ingredients and a preference for supplements derived from whole food sources. Vitamin K2, often sourced from natto or other fermented foods, aligns well with this consumer preference. Market data suggests that the natural supplement segment is expanding rapidly, with Vitamin K2 being a prominent player. This shift not only enhances the appeal of Vitamin K2 products but also positions the Vitamin K2 Market favorably in a competitive landscape where natural ingredients are increasingly sought after.

    Rising Incidence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases is a significant driver for the Vitamin K2 Market. Research has shown that Vitamin K2 may play a role in cardiovascular health by preventing arterial calcification and promoting proper blood clotting. As the global population ages, the prevalence of heart-related conditions is expected to rise, leading to a greater focus on preventive health measures. This has resulted in a growing interest in dietary supplements that support cardiovascular function, with Vitamin K2 being recognized for its potential benefits. Market analysts indicate that the cardiovascular health supplement sector is expanding, and Vitamin K2 is likely to be a key component in this growth. Consequently, the Vitamin K2 Market stands to benefit from the increasing consumer awareness of heart health and the desire for effective nutritional interventions.

    Regulatory Support for Nutritional Supplements

    Regulatory support for nutritional supplements is emerging as a crucial driver for the Vitamin K2 Market. Governments and health organizations are increasingly recognizing the importance of dietary supplements in promoting public health. This has led to the establishment of guidelines and regulations that support the safe use of vitamins and minerals, including Vitamin K2. Such regulatory frameworks not only enhance consumer confidence but also encourage manufacturers to invest in research and development. Market data suggests that the regulatory environment is becoming more favorable for the Vitamin K2 Market, facilitating the introduction of new products and formulations. As regulations evolve to support the nutritional supplement sector, the Vitamin K2 Market is likely to experience accelerated growth and innovation.

    Expansion of Nutraceuticals and Functional Foods

    The expansion of nutraceuticals and functional foods is driving the Vitamin K2 Market forward. As consumers seek foods that offer health benefits beyond basic nutrition, the incorporation of Vitamin K2 into various food products is becoming more prevalent. This trend is evident in the development of fortified foods and beverages that aim to enhance overall health. Market data indicates that the functional food sector is experiencing robust growth, with Vitamin K2 being recognized for its potential health benefits, including bone and cardiovascular support. This integration not only broadens the consumer base for Vitamin K2 but also enhances its visibility in the marketplace. As the demand for functional foods continues to rise, the Vitamin K2 Market is likely to see increased opportunities for innovation and product development.

    Market Segment Insights

    By Product Type: MK-7 (Largest) vs. MK-4 & Combination Drugs (Fastest-Growing)

    In the Vitamin K2 market, MK-7 holds a significant leading position, accounting for the largest share among product types due to its extensive application and consumer preference. MK-4 and combination drugs, while smaller in comparison, are rapidly gaining traction as awareness of their health benefits spreads. This segment is witnessing a shift as more consumers are becoming informed about the advantages of different forms of Vitamin K2, particularly in the context of bone and cardiovascular health.

    MK-7 (Dominant) vs. MK-4 & Combination Drugs (Emerging)

    MK-7 stands out as the dominant product type in the Vitamin K2 market, primarily because of its longer half-life resulting in better absorption and effectiveness in the human body. This has led to a strong consumer preference for MK-7 in dietary supplements. On the other hand, MK-4 and combination drugs are emerging rapidly, driven by increasing recognition of their potential health benefits and synergistic effects when combined with other vitamins and minerals. As health-conscious consumers seek a diverse array of supplements for overall wellness, MK-4's role in addressing specific health concerns is expected to enhance its market position in the coming years.

    By Source: Natural (Largest) vs. Synthetic (Fastest-Growing)

    In the Vitamin K2 market, the 'Natural' source holds a significant share, appealing to health-conscious consumers who prefer products derived from natural extracts. This segment is primarily driven by the increasing demand for clean-label products and a growing awareness about the health benefits associated with natural vitamins. On the other hand, the 'Synthetic' source is gaining traction, especially in cost-sensitive markets and among manufacturers looking for consistent quality and availability.

    Source: Natural (Dominant) vs. Synthetic (Emerging)

    The 'Natural' segment of Vitamin K2 is well-established, driven by consumer preferences for organic and whole food products that are perceived as safer and more effective. It typically boasts superior bioavailability, making it more attractive to consumers looking for efficacy in their dietary supplements. Conversely, the 'Synthetic' segment is rapidly emerging due to advancements in production technologies, which have made synthetic Vitamin K2 more accessible and affordable. While the natural source remains dominant, the synthetic segment is carving out a niche, particularly among manufacturers aiming to meet increasing market demand without compromising on quality.

    By Form: Capsules & Tablets (Largest) vs. Powder (Fastest-Growing)

    In the Vitamin K2 market, the distribution of the form segment is led by Capsules & Tablets, which stand as the most widely consumed forms due to their convenience and established presence. Capsules and tablets hold a significant market share, appealing especially to consumers seeking easy-to-dose options. In contrast, the Powder form, while smaller in market share, has been rapidly gaining traction, particularly among health enthusiasts and those who prefer customization in their supplement intake.

    Capsules & Tablets: Dominant vs. Powder: Emerging

    Capsules and Tablets are the dominant form in the Vitamin K2 market, favored for their portability and ease of use, making them a staple choice for consumers. This form benefits from extensive marketing and clinical endorsements, contributing to its established reputation. On the other hand, Powder has emerged as a favorite among health-conscious users who value the ability to mix supplements into beverages or foods. The growth of this segment is driven by the increasing popularity of health trends that favor flexibility in dosing and the appeal of powder forms in smoothie and health product formulations.

    By Application: Nutraceutical (Largest) vs. Food & Pharmaceutical (Fastest-Growing)

    In the Vitamin K2 market, the application segment showcases a robust distribution between nutraceuticals and food & pharmaceutical applications. Nutraceuticals hold the largest share due to the increasing consumer awareness regarding dietary supplements and their health benefits. This segment, driven by the rising incidences of health disorders, reflects strong market dominance, supported by a growing trend of maintaining health and wellness through preventive measures. On the other hand, food and pharmaceutical applications are gaining traction as more stakeholders recognize the versatile health benefits of Vitamin K2. This shift stems from the product's adaptability and its integration into diverse health formulations, thereby boosting the overall market.

    Application: Nutraceutical (Dominant) vs. Food & Pharmaceutical (Emerging)

    The Nutraceutical application is currently the dominant segment within the Vitamin K2 market, characterized by a wide range of dietary supplements aimed at enhancing health and wellness. This segment benefits from consumers' increasing preference for preventive healthcare solutions, making it a staple in many health-conscious lifestyles. Meanwhile, the Food & Pharmaceutical application is an emerging segment, rapidly gaining importance as more manufacturers incorporate Vitamin K2 into functional foods and medical products. This shift is propelled by research highlighting its benefits, like bone health and cardiovascular support. As the food and pharmaceutical sectors move towards integrating more nutritional benefits into their offerings, the competition between these segments is expected to intensify.

    Get more detailed insights about Vitamin K2 Market

    Regional Insights

    North America : Health-Conscious Market Leader

    North America is the largest market for Vitamin K2, accounting for approximately 40% of global consumption. The region's growth is driven by increasing awareness of health benefits associated with Vitamin K2, particularly in bone and cardiovascular health. Regulatory support from agencies like the FDA has also catalyzed market expansion, encouraging product innovation and safety standards. The United States leads the North American market, with significant contributions from Canada. Key players such as Ginkgo BioWorks and Nutraceutical Corporation are actively involved in research and development, enhancing product offerings. The competitive landscape is characterized by a mix of established companies and emerging startups, all vying for market share in this lucrative sector.

    Europe : Regulatory-Driven Growth

    Europe is the second-largest market for Vitamin K2, holding around 30% of the global share. The region's growth is propelled by stringent regulations and increasing consumer demand for dietary supplements. The European Food Safety Authority (EFSA) has recognized the health benefits of Vitamin K2, which has led to a surge in product approvals and market entries, particularly in the nutraceutical sector. Leading countries in Europe include Germany, France, and the Netherlands, where awareness of Vitamin K2's benefits is rising. Key players like Kappa Bioscience and DSM Nutritional Products are at the forefront, driving innovation and expanding their product lines. The competitive landscape is robust, with a mix of local and international brands competing for consumer attention.

    Asia-Pacific : Rapidly Growing Market

    Asia-Pacific is witnessing rapid growth in the Vitamin K2 market, accounting for approximately 20% of global consumption. The region's demand is driven by rising health awareness and an increasing aging population. Countries like Japan and China are leading the charge, with supportive government policies promoting health supplements and functional foods, which are crucial for market expansion. Japan is particularly notable for its advanced nutraceutical market, where companies like NattoPharma are making significant inroads. The competitive landscape is evolving, with both local and international players striving to capture market share. The increasing focus on preventive healthcare is further propelling the demand for Vitamin K2 products across the region.

    Middle East and Africa : Emerging Nutraceutical Hub

    The Middle East and Africa region is emerging as a potential market for Vitamin K2, holding about 10% of the global share. The growth is primarily driven by increasing health awareness and a shift towards preventive healthcare. Governments in the region are beginning to recognize the importance of dietary supplements, which is fostering a more favorable regulatory environment for Vitamin K2 products. Countries like South Africa and the UAE are leading the market, with a growing number of local manufacturers entering the space. The competitive landscape is still developing, but key players are beginning to establish a presence. As consumer awareness increases, the demand for Vitamin K2 is expected to rise significantly in the coming years.

    Key Players and Competitive Insights

    The Vitamin K2 Market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding health benefits and a growing demand for dietary supplements. Key players such as NattoPharma (NO), Kappa Bioscience (NO), and DSM Nutritional Products (CH) are strategically positioned to leverage these trends. NattoPharma (NO) focuses on innovation in product development, particularly in enhancing the bioavailability of Vitamin K2, which appears to resonate well with health-conscious consumers. Kappa Bioscience (NO) emphasizes regional expansion, particularly in Asia, where the demand for Vitamin K2 is surging. Meanwhile, DSM Nutritional Products (CH) is investing in digital transformation initiatives to streamline its supply chain and enhance customer engagement, indicating a shift towards more integrated operational models. Collectively, these strategies contribute to a moderately fragmented market structure, where competition is intensifying as companies seek to differentiate themselves through innovation and operational efficiency.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain resilience. This approach not only enhances responsiveness to market demands but also aligns with sustainability goals, as local production often results in lower carbon footprints. The competitive structure of the Vitamin K2 Market remains moderately fragmented, with several key players exerting influence over pricing and product offerings. The collective actions of these companies suggest a trend towards consolidation, as smaller firms may struggle to compete against the operational scale and innovation capabilities of larger entities.

    In August 2025, NattoPharma (NO) announced a partnership with a leading health food retailer to launch a new line of Vitamin K2-enriched products aimed at the growing vegan market. This strategic move is significant as it not only expands NattoPharma's product portfolio but also taps into a demographic that is increasingly seeking plant-based nutritional options. The partnership is likely to enhance brand visibility and drive sales in a competitive segment.

    In September 2025, Kappa Bioscience (NO) unveiled a new manufacturing facility in Singapore, aimed at increasing production capacity to meet the rising demand in the Asia-Pacific region. This expansion is crucial, as it positions Kappa Bioscience to capitalize on the burgeoning market for dietary supplements in Asia, where awareness of Vitamin K2's health benefits is rapidly increasing. The facility is expected to enhance supply chain efficiency and reduce lead times for customers in the region.

    In October 2025, DSM Nutritional Products (CH) launched an innovative digital platform designed to provide real-time data analytics for its Vitamin K2 product line. This initiative reflects a broader trend towards digitalization in the industry, enabling DSM to offer tailored solutions to its clients and improve customer engagement. The platform is anticipated to enhance decision-making processes and optimize inventory management, thereby reinforcing DSM's competitive edge in the market.

    As of October 2025, the Vitamin K2 Market is witnessing trends that emphasize digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of agility and responsiveness in a market that is becoming increasingly complex and consumer-driven.

    Key Companies in the Vitamin K2 Market market include

    Industry Developments

    • Q1 2024: Gnosis by Lesaffre Launches New Vitamin K2 Ingredient for Functional Foods Gnosis by Lesaffre announced the launch of its new MenaQ7® Matrix, a microencapsulated vitamin K2 ingredient designed for use in functional foods and beverages, expanding its product portfolio in the vitamin K2 sector.
    • Q2 2024: Balchem Expands Vitamin K2 Production Capacity with New Facility in Missouri Balchem Corporation opened a new manufacturing facility in Missouri dedicated to increasing production of vitamin K2, aiming to meet rising global demand for the nutrient in dietary supplements and fortified foods.
    • Q2 2024: Kappa Bioscience Appoints New CEO to Drive Vitamin K2 Growth Strategy Kappa Bioscience announced the appointment of a new Chief Executive Officer, signaling a renewed focus on innovation and expansion in the vitamin K2 market.
    • Q3 2024: NattoPharma Receives Regulatory Approval for Vitamin K2 Ingredient in Brazil NattoPharma secured regulatory approval from Brazilian health authorities for its MenaQ7® vitamin K2 ingredient, enabling expanded distribution in the Latin American market.
    • Q3 2024: DSM-Firmenich Announces Strategic Partnership with Asian Supplement Brand for Vitamin K2 Products DSM-Firmenich entered into a strategic partnership with a leading Asian supplement brand to co-develop and market new vitamin K2-enriched products targeting bone and cardiovascular health.
    • Q4 2024: Balchem Acquires Minority Stake in Vitamin K2 Startup Innovo Nutrition Balchem Corporation acquired a minority equity stake in Innovo Nutrition, a startup specializing in plant-based vitamin K2, to accelerate innovation and expand its product offerings.
    • Q4 2024: Gnosis by Lesaffre Partners with European Dairy Producer to Launch K2-Fortified Yogurt Gnosis by Lesaffre announced a partnership with a major European dairy producer to launch a new line of yogurt products fortified with its MenaQ7® vitamin K2 ingredient.
    • Q1 2025: Kappa Bioscience Launches Vegan Vitamin K2 Ingredient for Supplement Market Kappa Bioscience introduced a new vegan-certified vitamin K2 ingredient, expanding its portfolio to meet growing demand for plant-based and vegan supplements.
    • Q2 2025: Amway Nutrilite Launches Vitamin K2 Supplement Targeting Bone Health Amway's Nutrilite brand launched a new vitamin K2 supplement formulated to support bone health, marking its entry into the rapidly growing K2 supplement segment.
    • Q2 2025: NattoPharma Signs Supply Agreement with Major US Retailer for Vitamin K2 Products NattoPharma entered into a multi-year supply agreement with a major US retailer to provide its MenaQ7® vitamin K2 for use in private-label dietary supplements.
    • Q3 2025: Balchem Announces Expansion of Vitamin K2 Distribution in Asia-Pacific Balchem Corporation expanded its vitamin K2 distribution network in the Asia-Pacific region through new partnerships with regional supplement manufacturers.
    • Q3 2025: Gnosis by Lesaffre Receives Novel Food Approval for Vitamin K2 in China Gnosis by Lesaffre received novel food approval from Chinese regulatory authorities for its MenaQ7® vitamin K2, enabling commercial sales in the Chinese market.

    Future Outlook

    Vitamin K2 Market Future Outlook

    The Vitamin K2 market is projected to grow at a 4.52% CAGR from 2024 to 2035, driven by increasing health awareness, dietary supplement demand, and advancements in production technologies.

    New opportunities lie in:

    • Expansion into emerging markets with tailored marketing strategies.
    • Development of innovative delivery systems for enhanced bioavailability.
    • Partnerships with health professionals to promote K2 benefits in preventive care.

    By 2035, the Vitamin K2 market is expected to achieve substantial growth and increased market penetration.

    Market Segmentation

    Vitamin K2 Market Form Outlook

    • Capsules & Tablets
    • Powder
    • Oil

    Vitamin K2 Market Source Outlook

    • Natural
    • Synthetic

    Vitamin K2 Market Application Outlook

    • Nutraceutical
    • Food & Pharmaceutical

    Vitamin K2 Market Product Type Outlook

    • MK-7
    • MK-4 & Combination Drugs

    Report Scope

    MARKET SIZE 2024122.29(USD Billion)
    MARKET SIZE 2025127.82(USD Billion)
    MARKET SIZE 2035198.88(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.52% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesGrowing consumer awareness of health benefits drives demand in the Vitamin K2 Market.
    Key Market DynamicsRising consumer awareness of health benefits drives demand for Vitamin K2 supplements and fortified foods.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How much is the vitamin K2 market?

    The vitamin K2 market size was valued at USD 85.4 Billion in 2021.

    What is the growth rate of the vitamin K2 market?

    The global market is projected to grow at a CAGR of 11.5% during the forecast period, 2024-2035.

    Which region held the largest market share in the vitamin K2 market?

    In 2021, North America had the largest revenue share of the global market.

    Who are the key players in the vitamin K2 market?

    The key players in the market are Lesaffre (France), Kappa Bioscience (Norway), Seebio Biotech (Shanghai) Co. Ltd (China), Viridis BioPharma (India), and DSM (Netherlands).

    Which product type led the vitamin K2 market?

    The MK-7 category dominated the global market in 2021.

    Which application had the largest market share in the vitamin K2 market?

    In 2021, food & pharmaceutical had the largest global market share.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions